Multi-omics characterization identifies AHCY as a prognostic biomarker driving immunometabolic reprogramming in bladder cancer
多组学分析表明,AHCY 是一种驱动膀胱癌免疫代谢重编程的预后生物标志物
期刊:Translational Oncology
影响因子:4.1
doi:10.1016/j.tranon.2025.102652
Peng, Qiao; Zhang, Mengmei; Zhao, Shuyu; Guo, Yadong; Shan, Minjue; Su, Baimei; Mao, Shiyu; Shi, Donghui; Lin, Ziyou
肿瘤
肿瘤免疫
代谢
代谢重编程
免疫代谢
膀胱癌
免疫/内分泌